Zim Laboratories Limited.

BSE: 541400
Zim Laboratories Limited. - pharma in Nagpur, Maharashtra, India. FY 2026 financials and compliance.
CIN L99999MH1984PLC032172 Incorporated 14 February 1984 ROC Mumbai HQ Nagpur, Maharashtra, India
Active Listed - BSE: 541400 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹374.4 Cr
▼ 1.22% YoY
EBITDA · FY 2026
₹41.39 Cr
▼ 16.4% YoY
Net profit · FY 2026
₹5.84 Cr
▼ 52.01% YoY
Authorised capital
₹75 Cr
Registered with MCA
Paid-up capital
₹48.74 Cr
Issued & subscribed
Open charges
₹182.69 Cr
Satisfied ₹530.82 Cr
Company age
42 yrs
Est. 1984
Employees · EPFO
586
Latest available

About Zim Laboratories Limited.

Data last updated: 19 January 2026

Zim Laboratories Limited. is a public limited company based in Nagpur, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 14 February 1984, the company has been in operation for over 42 years.

Registered with ROC Mumbai under CIN L99999MH1984PLC032172. Listed on BSE: 541400.

Capital: an authorised share capital of ₹75 Cr and a paid-up capital of ₹48.74 Cr. It is led by directors including Niraj Pukhraj Dhadiwal and Prakash Pralahadrao Sapkal.

Last AGM: 27 June 2025. Financial statements filed for year ended 31 March 2025. Office: Sadoday Gyan(Ground Floor) Opp.Nadt Nelson Square, Nagpur, Maharashtra, India – 440013.

As per the financials filed for FY 2025, the company reported a revenue of ₹384.82 Cr, a growth of 3% compared to the previous year.

The company has a workforce of approximately 586 employees as per the latest available data. Its group structure includes 2 subsidiaries.

The company is associated with 1 brand - Zim Labs. As per MCA filings, the company has open charges of ₹182.69 Cr and satisfied charges of ₹530.82 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zimlab.in.

Company Details of Zim Laboratories Limited.
CIN L99999MH1984PLC032172
Registration Number 032172
Incorporation Date 14 February 1984
ROC Mumbai
Listing Status Listed (BSE: 541400)
Company Status Active
Date of Last AGM 27 June 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Anwar Siraj Daud Managing Director Niraj Pukhraj Dhadiwal Whole-Time Director Prakash Pralahadrao Sapkal Whole-Time Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    zimlab.in
  • Social Media
  • Registered Address
    Sadoday Gyan(Ground Floor) Opp.Nadt Nelson Square, Nagpur, Maharashtra, India – 440013
  • Industry
    Pharma, Drug Formulation & Development
Company report
Zim Laboratories Limited. - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Zim Laboratories Limited. report

Financials, compliance, directors, charges, ownership and filings for Zim Laboratories Limited. in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Zim Laboratories Limited.

Zim Laboratories Limited. has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L99999MH1984PLC032172, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L99999MH1984PLC032172 Current
U99999MH1984PLC032172 Previous
L99999MH1984PTC032172 Previous

Associated Brands with Zim Laboratories Limited.

Zim Laboratories Limited. operates one associated brand: Zim Labs. These brands represent Zim Laboratories Limited.'s diversified market presence and brand portfolio.

Brand Description Website
Zim Labs
Solid and semisolid dosage forms are developed and manufactured. zimlab.in

Competitors & Alternatives of Zim Laboratories Limited.

Brands and companies operating in the same space as Zim Laboratories Limited. include Inventia Healthcare, Lotus, Contract Pharmacal Corp. and 6 more.

Competitor Description Location Founded
Inventia Healthcare Inventia Healthcare Oral solid drug delivery systems are manufactured and developed. Mumbai, India, India 1985
Lotus Lotus Contract manufacturing for oral solid formulations is offered. Taipei, Taiwan, Taiwan 1966
Contract Pharmacal Corp. Contract Pharmacal Corp. Product development, manufacturing and packaging services Hauppauge, United States, United States 1971
Adare Pharma Solutions Adare Pharma Solutions CDMO manufacturing solid drugs Lawrence Township, United States, United States 2015
Suzhou Ze Jing Biological Pharmaceutical Suzhou Ze Jing Biological Pharmaceutical Company developing small molecules & eukaryotic cell based recombinant protein drugs Suzhou, China, China 2009
Halewood Laboratories Halewood Laboratories Provides contract manufacturing services for food, pharmaceuticals, and related products globally. Ahmedabad, India, India 1984
Capsugel Capsugel Dosage forms are delivered for preclinical, clinical, and commercial supply. Morristown, United States, United States 1875
Tedor Pharma Tedor Pharma Turnkey development services for solid dosage forms are provided. Cumberland, United States, United States 2001
Norwich Pharma Norwich Pharma Offers a full range of solid dose manufacturing and packaging Norwich, United States, United States 1887

Business Activity of Zim Laboratories Limited.

Zim Laboratories Limited. is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Zim Laboratories Limited.

Zim Laboratories Limited. is audited by Deloitte Haskins & Sells LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Deloitte Haskins & Sells LLP (ICAI peer reviewed, certificate valid till 2027-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Zim Laboratories Limited.

Zim Laboratories Limited. is currently managed by 10 directors, with 18 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Niraj Pukhraj Dhadiwal Whole-Time Director 22 Nov 2013 12 Years 7 Months Current
Prakash Pralahadrao Sapkal
Also directs: Zim Thinorals Private Limited
Whole-Time Director 22 Nov 2013 12 Years 7 Months Current
Anwar Siraj Daud
Also directs: Zim Health Technologies Limited, Zim Thinorals Private Limited
Managing Director 01 Apr 2009 17 Years 3 Months Current
Ashok Ramprakash Bhatia
Also directs: Onnext Advisors Llp, Shalby Limited
Director 01 Apr 2025 1 Years 3 Months Current
Kamlesh Bajirao Shende Director 01 Apr 2022 4 Years 3 Months Current
Zulfiquar Murtaza Kamal
Also directs: Zim Health Technologies Limited, Zim Thinorals Private Limited, Falcon Knowledge Services Private Limited and 1 more
Whole-Time Director 19 Oct 2012 13 Years 8 Months Current
Showing 6 of 10 current directors. View all directors

Financials of Zim Laboratories Limited. FY 2026 filings available

Zim Laboratories Limited. reported revenue of ₹374.4 Cr (down 1.22% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹374.4 Cr ▼ 1.22%
Profit · FY 2026
₹5.84 Cr ▼ 52.01%
EBITDA · FY 2026
₹41.39 Cr ▼ 16.4%
Revenue₹ Cr · Consolidated0200400FY 2023: ₹399 Cr399FY 2023FY 2024: ₹367 Cr · -7.8% YoY367-7.8%FY 2024FY 2025: ₹379 Cr · +3.2% YoY379+3.2%FY 2025FY 2026: ₹374 Cr · -1.2% YoY374-1.2%FY 2026
Net Profit₹ Cr · Consolidated0102030FY 2023: ₹24 Cr24.4FY 2023FY 2024: ₹17 Cr · -29.4% YoY17.2-29.4%FY 2024FY 2025: ₹12 Cr · -29.5% YoY12.2-29.5%FY 2025FY 2026: ₹6 Cr · -52% YoY5.8-52%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year050100150Q1'25: ₹82 Cr · +21.3% YoY81.8+21.3%Q1'25Q2'25: ₹92 Cr · +7.4% YoY92.1+7.4%Q2'25Q3'25: ₹96 Cr · +0% YoY96.3+0%Q3'25Q4'25: ₹109 Cr · -7.7% YoY109-7.7%Q4'25Q1'26: ₹72 Cr · -12.3% YoY71.8-12.3%Q1'26Q2'26: ₹89 Cr · -3.7% YoY88.7-3.7%Q2'26Q3'26: ₹109 Cr · +12.8% YoY109+12.8%Q3'26Q4'26: ₹105 Cr · -3.2% YoY105-3.2%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Revenue from Operations ₹374.4 Cr ₹379.03 Cr ₹367.42 Cr ₹398.53 Cr
Other Income ₹11.38 Cr ₹5.78 Cr ₹5.18 Cr ₹6.41 Cr
Total Income ₹385.78 Cr ₹384.82 Cr ₹372.61 Cr ₹404.94 Cr
Cost of Materials Consumed ₹164.05 Cr ₹155 Cr ₹177.7 Cr ₹164.98 Cr
Purchases of Stock-in-Trade ₹7.47 Cr ₹11.58 Cr ₹7.8 Cr ₹17.39 Cr
Changes in Inventories -₹6.14 Cr ₹1.27 Cr -₹14.05 Cr ₹16.46 Cr
Employee Benefit Expense ₹63.9 Cr ₹60.76 Cr ₹53.34 Cr ₹49.32 Cr
Finance Costs ₹13.2 Cr ₹11.39 Cr ₹6.92 Cr ₹5.58 Cr
Depreciation & Amortisation ₹19.98 Cr ₹20.11 Cr ₹15.95 Cr ₹17.47 Cr
Other Expenses ₹115.11 Cr ₹106.7 Cr ₹101.31 Cr ₹98.38 Cr
Total Expenses ₹377.57 Cr ₹366.81 Cr ₹348.97 Cr ₹369.59 Cr
Profit Before Exceptional Items & Tax ₹8.21 Cr ₹18.01 Cr ₹23.64 Cr ₹35.36 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹8.21 Cr ₹18.01 Cr ₹23.64 Cr ₹35.36 Cr
Total Tax Expense ₹2.37 Cr ₹5.84 Cr ₹6.4 Cr ₹10.92 Cr
Net Profit ₹5.84 Cr ₹12.17 Cr ₹17.25 Cr ₹24.43 Cr
  attributable to Owners ₹5.84 Cr ₹12.17 Cr ₹17.25 Cr ₹24.43 Cr
  attributable to NCI ₹0 -₹2,000 -₹1,000 ₹0
Other Comprehensive Income ₹2.11 Cr -₹2.75 Lakh -₹24.9 Lakh ₹67.7 Lakh
Total Comprehensive Income ₹7.94 Cr ₹12.14 Cr ₹17 Cr ₹25.11 Cr
EBITDA (computed) ₹41.39 Cr ₹49.51 Cr ₹46.52 Cr ₹58.4 Cr
Basic EPS ₹1.19 ₹2.50 ₹3.54 ₹5.01
Diluted EPS ₹1.19 ₹2.50 ₹3.54 ₹5.01
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹539.39 Cr ₹472.02 Cr ₹446.82 Cr ₹341.58 Cr
Non-current Assets ₹263.58 Cr ₹240.72 Cr ₹219.17 Cr ₹150.63 Cr
Current Assets ₹275.81 Cr ₹231.31 Cr ₹227.65 Cr ₹190.95 Cr
Property, Plant & Equipment ₹156.43 Cr ₹158.34 Cr ₹156.93 Cr ₹103.72 Cr
Inventories ₹93.77 Cr ₹86.47 Cr ₹81.26 Cr ₹53.71 Cr
Trade Receivables ₹109.04 Cr ₹106.92 Cr ₹100.17 Cr ₹95.25 Cr
Cash & Equivalents ₹25.12 Cr ₹1.95 Cr ₹9.6 Cr ₹6.42 Cr
Equity (Net Worth) ₹296.15 Cr ₹252.24 Cr ₹238.75 Cr ₹200.35 Cr
Equity Share Capital ₹53.5 Cr ₹48.73 Cr ₹48.73 Cr ₹48.73 Cr
Borrowings (Non-current) ₹41.59 Cr ₹40.3 Cr ₹35.6 Cr ₹24.62 Cr
Borrowings (Current) ₹81.4 Cr ₹71.86 Cr ₹70.75 Cr ₹34.94 Cr
Total Debt (computed) ₹122.98 Cr ₹112.17 Cr ₹106.35 Cr ₹59.57 Cr
Current Liabilities ₹190.39 Cr ₹166.36 Cr ₹159.43 Cr ₹110.79 Cr
Total Liabilities ₹243.23 Cr ₹219.79 Cr ₹208.08 Cr ₹141.23 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Operating Cash Flow ₹49.53 Cr ₹41.15 Cr ₹16.28 Cr ₹37.52 Cr
Investing Cash Flow -₹56.35 Cr -₹39.93 Cr -₹73.01 Cr -₹36.2 Cr
Financing Cash Flow ₹28.19 Cr -₹9.1 Cr ₹59.53 Cr ₹54.56 Lakh
Capital Expenditure ₹44.39 Cr ₹40.8 Cr ₹73.92 Cr ₹36.67 Cr
Free Cash Flow (computed) ₹5.15 Cr ₹35.69 Lakh -₹57.65 Cr ₹85.16 Lakh
Dividends Paid ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹23.18 Cr -₹7.65 Cr ₹3.18 Cr ₹3 Cr
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹105.27 Cr ₹108.66 Cr ₹88.71 Cr ₹71.76 Cr ₹108.73 Cr ₹96.33 Cr ₹92.14 Cr ₹81.82 Cr ₹117.86 Cr ₹96.29 Cr ₹85.83 Cr ₹67.44 Cr
Other Income ₹6.16 Cr ₹1.7 Cr ₹2.04 Cr ₹1.48 Cr ₹1.71 Cr ₹1.75 Cr ₹1.32 Cr ₹99.89 Lakh ₹1.53 Cr ₹1.11 Cr ₹1.42 Cr ₹1.12 Cr
Total Income ₹111.44 Cr ₹110.36 Cr ₹90.75 Cr ₹73.23 Cr ₹110.44 Cr ₹98.08 Cr ₹93.46 Cr ₹82.82 Cr ₹119.4 Cr ₹97.4 Cr ₹87.25 Cr ₹68.56 Cr
Cost of Materials Consumed ₹49.7 Cr ₹43.23 Cr ₹43.5 Cr ₹27.62 Cr ₹48.6 Cr ₹39.88 Cr ₹35.52 Cr ₹31.01 Cr ₹53.49 Cr ₹51.51 Cr ₹40.96 Cr ₹31.74 Cr
Purchases of Stock-in-Trade ₹2.36 Cr ₹58.68 Lakh ₹2.93 Cr ₹1.59 Cr ₹3.3 Cr ₹2.49 Cr ₹3.14 Cr ₹2.66 Cr ₹2.12 Cr ₹3.01 Cr ₹2.04 Cr ₹63.09 Lakh
Changes in Inventories -₹4.94 Cr ₹4.78 Cr -₹6.78 Cr ₹79.86 Lakh -₹3.64 Cr -₹1.11 Cr ₹3.45 Cr ₹2.56 Cr ₹58.65 Lakh -₹10.3 Cr -₹3.08 Cr -₹1.26 Cr
Employee Benefit Expense ₹17.39 Cr ₹15.58 Cr ₹16.32 Cr ₹14.61 Cr ₹16.32 Cr ₹14.47 Cr ₹15.45 Cr ₹14.51 Cr ₹14.71 Cr ₹13.17 Cr ₹12.83 Cr ₹12.63 Cr
Finance Costs ₹3.31 Cr ₹3.43 Cr ₹3.16 Cr ₹3.3 Cr ₹2.91 Cr ₹2.73 Cr ₹2.89 Cr ₹2.86 Cr ₹2.28 Cr ₹1.7 Cr ₹1.22 Cr ₹1.73 Cr
Depreciation & Amortisation ₹5.1 Cr ₹5.03 Cr ₹4.98 Cr ₹4.86 Cr ₹5.29 Cr ₹4.88 Cr ₹5 Cr ₹4.94 Cr ₹3.91 Cr ₹3.94 Cr ₹4.09 Cr ₹4.03 Cr
Other Expenses ₹33.56 Cr ₹31.68 Cr ₹26.99 Cr ₹22.88 Cr ₹29.56 Cr ₹29.04 Cr ₹25.05 Cr ₹23.05 Cr ₹31.31 Cr ₹27.37 Cr ₹23.76 Cr ₹18.87 Cr
Total Expenses ₹106.49 Cr ₹104.31 Cr ₹91.1 Cr ₹75.66 Cr ₹102.33 Cr ₹92.38 Cr ₹90.5 Cr ₹81.59 Cr ₹108.4 Cr ₹90.39 Cr ₹81.8 Cr ₹68.37 Cr
Profit Before Exceptional Items & Tax ₹4.94 Cr ₹6.05 Cr -₹34.38 Lakh -₹2.43 Cr ₹8.11 Cr ₹5.7 Cr ₹2.96 Cr ₹1.23 Cr ₹11 Cr ₹7.01 Cr ₹5.44 Cr ₹18.54 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹4.94 Cr ₹6.05 Cr -₹34.38 Lakh -₹2.43 Cr ₹8.11 Cr ₹5.7 Cr ₹2.96 Cr ₹1.23 Cr ₹11 Cr ₹7.01 Cr ₹5.44 Cr ₹18.54 Lakh
Total Tax Expense ₹1.2 Cr ₹1.65 Cr ₹8.08 Lakh -₹55.71 Lakh ₹3.22 Cr ₹1.7 Cr ₹58.15 Lakh ₹33.61 Lakh ₹2.91 Cr ₹2.23 Cr ₹1.29 Cr -₹4.12 Lakh
Net Profit ₹3.74 Cr ₹4.4 Cr -₹42.46 Lakh -₹1.87 Cr ₹4.88 Cr ₹4 Cr ₹2.38 Cr ₹89.83 Lakh ₹8.09 Cr ₹4.78 Cr ₹4.15 Cr ₹22.66 Lakh
  attributable to Owners ₹3.74 Cr ₹4.4 Cr -₹42.46 Lakh -₹1.87 Cr ₹4.88 Cr ₹4 Cr ₹2.38 Cr ₹89.83 Lakh ₹8.09 Cr ₹4.78 Cr ₹4.15 Cr ₹22.66 Lakh
  attributable to NCI ₹1,000 -₹1,000 ₹0 ₹0 -₹2,000 ₹0 ₹0 ₹0 -₹1,000 ₹0 ₹0 ₹0
Other Comprehensive Income ₹49.63 Lakh ₹86.67 Lakh ₹32.48 Lakh ₹41.89 Lakh -₹39.24 Lakh ₹28.25 Lakh ₹15.29 Lakh -₹7.05 Lakh -₹7.06 Lakh -₹4.21 Lakh ₹77,000 -₹14.4 Lakh
Total Comprehensive Income ₹4.24 Cr ₹5.26 Cr -₹9.98 Lakh -₹1.46 Cr ₹4.49 Cr ₹4.28 Cr ₹2.53 Cr ₹82.78 Lakh ₹8.02 Cr ₹4.74 Cr ₹4.16 Cr ₹8.26 Lakh
EBITDA (computed) ₹13.35 Cr ₹14.51 Cr ₹7.8 Cr ₹5.74 Cr ₹16.31 Cr ₹13.32 Cr ₹10.85 Cr ₹9.04 Cr ₹17.18 Cr ₹12.65 Cr ₹10.75 Cr ₹5.95 Cr
Basic EPS ₹0.76 ₹0.90 ₹-0.09 ₹-0.38 ₹1.01 ₹0.82 ₹0.49 ₹0.18 ₹1.66 ₹0.98 ₹0.85 ₹0.05
Diluted EPS ₹0.76 ₹0.90 ₹-0.09 ₹-0.38 ₹1.01 ₹0.82 ₹0.49 ₹0.18 ₹1.66 ₹0.98 ₹0.85 ₹0.05
Latest 12 quarters shown of 14 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Revenue from Operations ₹370.48 Cr ₹375.64 Cr ₹365.47 Cr ₹396.53 Cr
Other Income ₹11.39 Cr ₹5.62 Cr ₹4.69 Cr ₹6.43 Cr
Total Income ₹381.87 Cr ₹381.26 Cr ₹370.16 Cr ₹402.96 Cr
Cost of Materials Consumed ₹163.19 Cr ₹155 Cr ₹177.7 Cr ₹164.98 Cr
Purchases of Stock-in-Trade ₹7.47 Cr ₹11.58 Cr ₹7.8 Cr ₹17.39 Cr
Changes in Inventories -₹6.14 Cr ₹1.27 Cr -₹14.05 Cr ₹16.46 Cr
Employee Benefit Expense ₹60.1 Cr ₹56.41 Cr ₹50.81 Cr ₹46.47 Cr
Finance Costs ₹13.2 Cr ₹11.39 Cr ₹6.92 Cr ₹5.58 Cr
Depreciation & Amortisation ₹19.37 Cr ₹19.89 Cr ₹14.83 Cr ₹16.13 Cr
Other Expenses ₹116.29 Cr ₹108.11 Cr ₹103.12 Cr ₹100.03 Cr
Total Expenses ₹373.47 Cr ₹363.64 Cr ₹347.12 Cr ₹367.04 Cr
Profit Before Exceptional Items & Tax ₹8.4 Cr ₹17.61 Cr ₹23.04 Cr ₹35.92 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹8.4 Cr ₹17.61 Cr ₹23.04 Cr ₹35.92 Cr
Total Tax Expense ₹2.44 Cr ₹5.87 Cr ₹6.28 Cr ₹10.91 Cr
Net Profit ₹5.97 Cr ₹11.74 Cr ₹16.76 Cr ₹25.01 Cr
Other Comprehensive Income -₹9.82 Lakh -₹53.84 Lakh -₹38.19 Lakh -₹46.16 Lakh
Total Comprehensive Income ₹5.87 Cr ₹11.21 Cr ₹16.37 Cr ₹24.55 Cr
EBITDA (computed) ₹40.97 Cr ₹48.89 Cr ₹44.79 Cr ₹57.62 Cr
Basic EPS ₹1.22 ₹2.41 ₹3.44 ₹5.13
Diluted EPS ₹1.22 ₹2.41 ₹3.44 ₹5.13
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹525.2 Cr ₹464.39 Cr ₹442.5 Cr ₹334.87 Cr
Non-current Assets ₹272.77 Cr ₹248.04 Cr ₹224.79 Cr ₹156.23 Cr
Current Assets ₹252.43 Cr ₹216.35 Cr ₹217.71 Cr ₹178.64 Cr
Property, Plant & Equipment ₹156.37 Cr ₹158.28 Cr ₹156.92 Cr ₹103.69 Cr
Inventories ₹93.77 Cr ₹86.47 Cr ₹81.26 Cr ₹53.71 Cr
Trade Receivables ₹92.28 Cr ₹93.68 Cr ₹100.09 Cr ₹88.36 Cr
Cash & Equivalents ₹18.8 Cr ₹36.36 Lakh ₹17.35 Lakh ₹1.11 Cr
Equity (Net Worth) ₹286.35 Cr ₹244.51 Cr ₹231.95 Cr ₹194.18 Cr
Equity Share Capital ₹53.5 Cr ₹48.73 Cr ₹48.73 Cr ₹48.73 Cr
Borrowings (Non-current) ₹41.59 Cr ₹40.3 Cr ₹35.6 Cr ₹24.62 Cr
Borrowings (Current) ₹81.4 Cr ₹71.86 Cr ₹70.75 Cr ₹34.94 Cr
Total Debt (computed) ₹122.98 Cr ₹112.17 Cr ₹106.35 Cr ₹59.57 Cr
Current Liabilities ₹186.01 Cr ₹166.2 Cr ₹161.9 Cr ₹110.24 Cr
Total Liabilities ₹238.85 Cr ₹219.87 Cr ₹210.55 Cr ₹140.69 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Operating Cash Flow ₹47.66 Cr ₹50.6 Cr ₹11.47 Cr ₹35.23 Cr
Investing Cash Flow -₹57.41 Cr -₹41.31 Cr -₹71.94 Cr -₹35.21 Cr
Financing Cash Flow ₹28.19 Cr -₹9.1 Cr ₹59.53 Cr ₹54.56 Lakh
Capital Expenditure ₹41.63 Cr ₹37.92 Cr ₹72.59 Cr ₹35.67 Cr
Free Cash Flow (computed) ₹6.03 Cr ₹12.69 Cr -₹61.12 Cr -₹44.24 Lakh
Dividends Paid ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹18.43 Cr ₹19.01 Lakh -₹93.63 Lakh ₹56.76 Lakh
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹102.85 Cr ₹107.81 Cr ₹88.39 Cr ₹71.43 Cr ₹108.52 Cr ₹95.4 Cr ₹89.72 Cr ₹82 Cr ₹117.39 Cr ₹95.82 Cr ₹85.26 Cr ₹67.01 Cr
Other Income ₹6.16 Cr ₹1.71 Cr ₹2.04 Cr ₹1.48 Cr ₹1.55 Cr ₹1.76 Cr ₹1.32 Cr ₹98.03 Lakh ₹1.53 Cr ₹1.11 Cr ₹1.42 Cr ₹63.24 Lakh
Total Income ₹109.01 Cr ₹109.52 Cr ₹90.44 Cr ₹72.9 Cr ₹110.07 Cr ₹97.16 Cr ₹91.04 Cr ₹82.98 Cr ₹118.92 Cr ₹96.93 Cr ₹86.68 Cr ₹67.64 Cr
Cost of Materials Consumed ₹48.85 Cr ₹43.23 Cr ₹43.5 Cr ₹27.62 Cr ₹48.6 Cr ₹39.88 Cr ₹35.52 Cr ₹31.01 Cr ₹53.49 Cr ₹51.51 Cr ₹40.96 Cr ₹31.74 Cr
Purchases of Stock-in-Trade ₹2.36 Cr ₹58.68 Lakh ₹2.93 Cr ₹1.59 Cr ₹3.3 Cr ₹2.49 Cr ₹3.14 Cr ₹2.66 Cr ₹2.12 Cr ₹3.01 Cr ₹2.04 Cr ₹63.09 Lakh
Changes in Inventories -₹5.12 Cr ₹4.97 Cr -₹6.78 Cr ₹79.86 Lakh -₹3.64 Cr -₹1.11 Cr ₹2.87 Cr ₹3.14 Cr ₹58.65 Lakh -₹10.3 Cr -₹3.08 Cr -₹1.26 Cr
Employee Benefit Expense ₹16.28 Cr ₹14.79 Cr ₹15.46 Cr ₹13.57 Cr ₹15.33 Cr ₹13.16 Cr ₹14.44 Cr ₹13.48 Cr ₹14.12 Cr ₹12.32 Cr ₹12.24 Cr ₹12.12 Cr
Finance Costs ₹3.31 Cr ₹3.43 Cr ₹3.16 Cr ₹3.3 Cr ₹2.91 Cr ₹2.73 Cr ₹2.89 Cr ₹2.86 Cr ₹2.28 Cr ₹1.7 Cr ₹1.22 Cr ₹1.73 Cr
Depreciation & Amortisation ₹4.9 Cr ₹4.85 Cr ₹4.83 Cr ₹4.79 Cr ₹5.23 Cr ₹4.77 Cr ₹4.97 Cr ₹4.92 Cr ₹3.87 Cr ₹3.58 Cr ₹3.72 Cr ₹3.66 Cr
Other Expenses ₹33.91 Cr ₹31.75 Cr ₹27.12 Cr ₹23.51 Cr ₹29.69 Cr ₹29.22 Cr ₹25.37 Cr ₹23.84 Cr ₹31.65 Cr ₹28.1 Cr ₹24.13 Cr ₹19.23 Cr
Total Expenses ₹104.49 Cr ₹103.59 Cr ₹90.21 Cr ₹75.19 Cr ₹101.42 Cr ₹91.13 Cr ₹89.19 Cr ₹81.9 Cr ₹108.12 Cr ₹89.92 Cr ₹81.23 Cr ₹67.86 Cr
Profit Before Exceptional Items & Tax ₹4.53 Cr ₹5.93 Cr ₹22.81 Lakh -₹2.28 Cr ₹8.65 Cr ₹6.03 Cr ₹1.85 Cr ₹1.08 Cr ₹10.8 Cr ₹7.01 Cr ₹5.45 Cr -₹22.26 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹4.53 Cr ₹5.93 Cr ₹22.81 Lakh -₹2.28 Cr ₹8.65 Cr ₹6.03 Cr ₹1.85 Cr ₹1.08 Cr ₹10.8 Cr ₹7.01 Cr ₹5.45 Cr -₹22.26 Lakh
Total Tax Expense ₹1.24 Cr ₹1.67 Cr ₹11.21 Lakh -₹59.1 Lakh ₹3.23 Cr ₹1.68 Cr ₹63.59 Lakh ₹32.52 Lakh ₹2.91 Cr ₹2.18 Cr ₹1.27 Cr -₹7.96 Lakh
Net Profit ₹3.28 Cr ₹4.26 Cr ₹11.6 Lakh -₹1.69 Cr ₹5.42 Cr ₹4.35 Cr ₹1.22 Cr ₹75.9 Lakh ₹7.89 Cr ₹4.83 Cr ₹4.18 Cr -₹14.3 Lakh
Other Comprehensive Income ₹30.56 Lakh -₹13.46 Lakh -₹13.46 Lakh -₹13.46 Lakh -₹25.19 Lakh -₹9.55 Lakh -₹9.55 Lakh -₹9.55 Lakh -₹3.56 Lakh -₹11.54 Lakh -₹11.55 Lakh -₹11.54 Lakh
Total Comprehensive Income ₹3.59 Cr ₹4.12 Cr -₹1.86 Lakh -₹1.83 Cr ₹5.17 Cr ₹4.25 Cr ₹1.12 Cr ₹66.35 Lakh ₹7.85 Cr ₹4.71 Cr ₹4.06 Cr -₹25.84 Lakh
EBITDA (computed) ₹12.74 Cr ₹14.21 Cr ₹8.22 Cr ₹5.81 Cr ₹16.79 Cr ₹13.53 Cr ₹9.71 Cr ₹8.86 Cr ₹16.96 Cr ₹12.28 Cr ₹10.38 Cr ₹5.17 Cr
Basic EPS ₹0.67 ₹0.87 ₹0.03 ₹-0.35 ₹1.11 ₹0.89 ₹0.25 ₹0.16 ₹1.62 ₹0.99 ₹0.86 ₹-0.03
Diluted EPS ₹0.67 ₹0.87 ₹0.03 ₹-0.35 ₹1.11 ₹0.89 ₹0.25 ₹0.16 ₹1.62 ₹0.99 ₹0.86 ₹-0.03
Latest 12 quarters shown of 14 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Zim Laboratories Limited.. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Zim Laboratories Limited.

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 30.35%, domestic institutional investors hold 0.07%, retail and other public shareholders hold 69.58% of Zim Laboratories Limited.. The company had 16,636 shareholders on record.

Promoters: 30.35%DII (Domestic Institutional): 0.07%Retail & Others: 69.58%
Mar 2026
QUARTER
30.35% Promoters
0.07% DII (Domestic Institutional)
69.58% Retail & Others
Promoter holding - history
Now 30.35% · Mar 2026High 33.26% · Sep 2022Low 30.35% · Mar 2026
29%30.5%32%33.5%35%Sep 2022Jun 2023Mar 2024Dec 2024Sep 2025Sep 2022: 33.26%Dec 2022: 33.26%Mar 2023: 33.26%Jun 2023: 33.26%Sep 2023: 33.26%Dec 2023: 33.26%Mar 2024: 33.26%Jun 2024: 33.26%Sep 2024: 33.26%Dec 2024: 33.26%Mar 2025: 33.26%Jun 2025: 33.26%Sep 2025: 33.26%Dec 2025: 33.26%Mar 2026: 30.35%33.26%30.35%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters30.35%33.26%33.26%33.26%33.26%33.26%
Public69.65%66.74%66.74%66.74%66.74%66.74%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023
Promoters30.35%33.26%33.26%33.26%
Public69.65%66.74%66.74%66.74%
Promoter change (YoY, %pts)-2.91+0.00+0.00-

Board & Governance of Zim Laboratories Limited.

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Zim Laboratories Limited. has 8 directors - 4 independent and 4 executive. The board is chaired by Anwar Daud.

DirectorPositionOn board sinceListed boards
Anwar Daud Executive Director · MD · Chairperson 2002-06-30 1
Zulfiquar Murtuza Kamal Executive Director 2012-10-19 1
Niraj Pukhraj Dhadiwal Executive Director 2013-11-22 1
Prakash Pralahadrao Sapkal Executive Director 2013-11-22 1
Kavita Loya Non-Executive - Independent Director 2017-09-21 1
Padmakar Shrinivas Joshi Non-Executive - Independent Director 2017-09-21 1
Kamlesh Bajirao Shende Non-Executive - Independent Director 2022-04-01 1
Ashok Bhatia Non-Executive - Independent Director 2025-04-01 2
Board Committees
CommitteeMembers
Audit Committee Kavita Loya (Chairperson), Padmakar Shrinivas Joshi, Zulfiquar Murtuza Kamal
Nomination and remuneration committee Padmakar Shrinivas Joshi (Chairperson), Kavita Loya, Ashok Bhatia, Anwar Daud
Stakeholders Relationship Committee Kavita Loya (Chairperson), Kamlesh Bajirao Shende, Prakash Pralahadrao Sapkal
Risk Management Committee Padmakar Shrinivas Joshi (Chairperson), Kamlesh Bajirao Shende, Kavita Loya, Anwar Daud
Corporate Social Responsibility Committee Kamlesh Bajirao Shende (Chairperson), Padmakar Shrinivas Joshi, Niraj Pukhraj Dhadiwal

Group Structure of Zim Laboratories Limited.

Zim Laboratories Limited. has 2 subsidiary companies. This group structure data is as of FY 2024. The corporate group structure reflects Zim Laboratories Limited.'s business expansion strategy and organizational complexity.

2
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Zim Health Technologies Limited U24100MH2009PLC193240 -
Zim Thinorals Private Limited U24297MH2021PTC360634 -

Showing major subsidiaries. Total: 2.

Charges & Borrowings of Zim Laboratories Limited.

Open charges
₹182.69 Cr
Satisfied charges
₹530.82 Cr
Breakdown by lending institutions
Bank of India₹172.69 Cr
Tata Capital Financial Services Limited₹10.00 Cr
Latest charge details
DateLenderAmountStatus
31 Oct 2023 Tata Capital Financial Services Limited ₹10 Cr Open
01 Feb 2013 Bank of India ₹172.69 Cr Open
28 Apr 2025 Bank of India ₹6.5 Cr Satisfied
29 May 2024 Others ₹16 Cr Satisfied
05 Apr 2024 Bank of India ₹6.5 Cr Satisfied

Total charge records: 51 View all charges

Employees and EPFO Compliance at Zim Laboratories Limited.

Zim Laboratories Limited. has a workforce of 586 employees as of Jan 19, 2026.

Employee count
586
Active EPFO establishments
1
Employee growth
-6.39%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Zim Laboratories Limited.

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Zim Laboratories Limited.

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Zim Laboratories Limited.

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Zim Laboratories Limited.

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Zim Laboratories Limited.

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Zim Laboratories Limited.

MSME Payment Delays by Zim Laboratories Limited.

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Zim Laboratories Limited.

Subsidiaries & Group Companies of Zim Laboratories Limited.

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Zim Laboratories Limited. with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Zim Laboratories Limited.

MCA Filings & Documents of Zim Laboratories Limited.

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Zim Laboratories Limited.

Charges
27 Oct 2025
A charge registered on 28 Apr 2025 via Charge ID 101086825 with Bank Of India was fully satisfied on 27 Oct 2025.
Activity
27 Jun 2025
Zim Laboratories Limited. last Annual general meeting of members was held on 27 Jun 2025 as per latest MCA records.
Charges
28 Apr 2025
A charge with Bank Of India amounted to Rs. 6.50 Cr with Charge ID 101086825 was registered on 28 Apr 2025.
Directors
01 Apr 2025
Ashok Ramprakash Bhatia was appointed as a Director on 01 Apr 2025 & has been associated with this company since 1 year 3 months.
Activity
31 Mar 2025
Zim Laboratories Limited. has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
09 Dec 2024
A charge registered on 29 May 2024 via Charge ID 100934913 with Others was fully satisfied on 09 Dec 2024.

Recent News on Zim Laboratories Limited.

ZIM Laboratories eyes regulated markets
07 Jun 2018 · Expressbpd

Frequently Asked Questions about Zim Laboratories Limited.

Zim Laboratories Limited. is an active public limited company in the pharma sector based in Nagpur, Maharashtra, India. It was incorporated on 14 February 1984 (42+ years old) and is registered under CIN L99999MH1984PLC032172. Listed on BSE: 541400. The company has 586 employees.

Zim Laboratories Limited. reported revenue of ₹384.82 Cr for FY 2025 (up 3.00% YoY).

The current directors of Zim Laboratories Limited. are:

The primary industry of Zim Laboratories Limited. is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Zim Laboratories Limited. is listed on BSE with code 541400.

Zim Laboratories Limited. can be reached at the registered office: Sadoday GyanGround Floor Opp.Nadt Nelson Square, Nagpur, Maharashtra, India – 440013, or through the website zimlab.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available